US Stock MarketDetailed Quotes

STRO Sutro Biopharma

Watchlist
  • 0.8332
  • -0.0668-7.42%
Trading Apr 24 11:13 ET
69.80MMarket Cap-0.28P/E (TTM)

Sutro Biopharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
-59.64%62.04M
-86.98%14.81M
-49.66%8.52M
146.89%25.71M
2.64%13.01M
126.84%153.73M
1,217.44%113.72M
-32.70%16.92M
-62.94%10.41M
114.92%12.67M
Operating revenue
-59.64%62.04M
-86.98%14.81M
-49.66%8.52M
146.89%25.71M
2.64%13.01M
126.84%153.73M
1,217.44%113.72M
-32.70%16.92M
-62.94%10.41M
114.92%12.67M
Cost of revenue
Gross profit
Operating expense
23.66%300.5M
13.46%80.07M
25.44%76.44M
31.45%74.39M
26.75%69.6M
23.53%243.01M
21.98%70.57M
31.45%60.94M
19.20%56.59M
21.95%54.91M
Selling and administrative expenses
-22.58%48.45M
-46.26%9.03M
-6.14%14.33M
-17.52%12.37M
-17.99%12.72M
5.11%62.58M
14.17%16.8M
4.28%15.27M
-0.95%15M
3.15%15.51M
-General and administrative expense
-22.58%48.45M
-46.26%9.03M
-6.14%14.33M
-17.52%12.37M
-17.99%12.72M
5.11%62.58M
14.17%16.8M
4.28%15.27M
-0.95%15M
3.15%15.51M
Research and development costs
39.69%252.04M
32.12%71.04M
36.00%62.11M
49.12%62.02M
44.36%56.88M
31.53%180.43M
24.64%53.77M
44.00%45.67M
28.64%41.59M
31.37%39.4M
Operating profit
-167.09%-238.45M
-251.23%-65.26M
-54.31%-67.92M
-5.43%-48.69M
-33.98%-56.59M
30.76%-89.28M
187.67%43.15M
-107.52%-44.01M
-138.29%-46.18M
-7.93%-42.24M
Net non-operating interest income expense
244.53%13.36M
-15.72%-4.83M
563.81%19.13M
-702.52%-4.13M
-1,144.37%-5.3M
-8,577.06%-9.24M
-247.96%-4.17M
-132.53%-4.13M
-29.72%-515K
21.26%-426K
Non-operating interest income
206.17%44.43M
-15.31%3.86M
494.33%27.04M
72.80%4.91M
60.00%4.1M
319.97%14.51M
114.19%4.56M
348.72%4.55M
1,342.64%2.84M
2,106.90%2.56M
Non-operating interest expense
30.82%31.07M
-0.48%8.69M
-8.82%7.91M
169.41%9.04M
214.70%9.4M
609.80%23.75M
1,360.03%8.73M
211.15%8.68M
465.15%3.36M
354.49%2.99M
Other net income (expense)
-42.22%4.81M
152.62%3.68M
-18.24%9.92M
-33.14%7.89M
-80.15%694K
322.72%8.32M
-1,341.92%-6.99M
Gain on sale of security
----
----
----
-42.22%4.81M
152.62%3.68M
-18.24%9.92M
-33.14%7.89M
-80.15%694K
322.72%8.32M
-1,341.92%-6.99M
Income before tax
-154.06%-225.1M
-249.53%-70.09M
-2.83%-48.79M
-25.11%-48.01M
-17.23%-58.21M
24.08%-88.6M
235.49%46.87M
-143.46%-47.45M
-63.21%-38.37M
-26.96%-49.66M
Income tax
-87.01%2.36M
-85.10%2.36M
0
-94.70%8K
0
627.68%18.19M
15.81M
1.84M
-93.96%151K
395K
Net income
-112.99%-227.46M
-333.20%-72.44M
1.01%-48.79M
-24.64%-48.02M
-16.31%-58.21M
10.41%-106.79M
189.80%31.07M
-152.89%-49.28M
-48.10%-38.52M
-27.97%-50.05M
Net income continuous Operations
-112.99%-227.46M
-333.20%-72.44M
1.01%-48.79M
-24.64%-48.02M
-16.31%-58.21M
10.41%-106.79M
189.80%31.07M
-152.89%-49.28M
-48.10%-38.52M
-27.97%-50.05M
Minority interest income
Net income attributable to the parent company
-112.99%-227.46M
-333.20%-72.44M
1.01%-48.79M
-24.64%-48.02M
-16.31%-58.21M
10.41%-106.79M
189.80%31.07M
-152.89%-49.28M
-48.10%-38.52M
-27.97%-50.05M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-112.99%-227.46M
-333.20%-72.44M
1.01%-48.79M
-24.64%-48.02M
-16.31%-58.21M
10.41%-106.79M
189.80%31.07M
-152.89%-49.28M
-48.10%-38.52M
-27.97%-50.05M
Basic earnings per share
-66.29%-2.96
-271.15%-0.89
27.16%-0.59
7.81%-0.59
-11.76%-0.95
24.26%-1.78
185.25%0.52
-118.92%-0.81
-16.36%-0.64
-1.19%-0.85
Diluted earnings per share
-66.29%-2.96
-271.15%-0.89
27.16%-0.59
7.81%-0.59
-11.76%-0.95
24.26%-1.78
185.25%0.52
-118.92%-0.81
-16.36%-0.64
-1.19%-0.85
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue -59.64%62.04M-86.98%14.81M-49.66%8.52M146.89%25.71M2.64%13.01M126.84%153.73M1,217.44%113.72M-32.70%16.92M-62.94%10.41M114.92%12.67M
Operating revenue -59.64%62.04M-86.98%14.81M-49.66%8.52M146.89%25.71M2.64%13.01M126.84%153.73M1,217.44%113.72M-32.70%16.92M-62.94%10.41M114.92%12.67M
Cost of revenue
Gross profit
Operating expense 23.66%300.5M13.46%80.07M25.44%76.44M31.45%74.39M26.75%69.6M23.53%243.01M21.98%70.57M31.45%60.94M19.20%56.59M21.95%54.91M
Selling and administrative expenses -22.58%48.45M-46.26%9.03M-6.14%14.33M-17.52%12.37M-17.99%12.72M5.11%62.58M14.17%16.8M4.28%15.27M-0.95%15M3.15%15.51M
-General and administrative expense -22.58%48.45M-46.26%9.03M-6.14%14.33M-17.52%12.37M-17.99%12.72M5.11%62.58M14.17%16.8M4.28%15.27M-0.95%15M3.15%15.51M
Research and development costs 39.69%252.04M32.12%71.04M36.00%62.11M49.12%62.02M44.36%56.88M31.53%180.43M24.64%53.77M44.00%45.67M28.64%41.59M31.37%39.4M
Operating profit -167.09%-238.45M-251.23%-65.26M-54.31%-67.92M-5.43%-48.69M-33.98%-56.59M30.76%-89.28M187.67%43.15M-107.52%-44.01M-138.29%-46.18M-7.93%-42.24M
Net non-operating interest income expense 244.53%13.36M-15.72%-4.83M563.81%19.13M-702.52%-4.13M-1,144.37%-5.3M-8,577.06%-9.24M-247.96%-4.17M-132.53%-4.13M-29.72%-515K21.26%-426K
Non-operating interest income 206.17%44.43M-15.31%3.86M494.33%27.04M72.80%4.91M60.00%4.1M319.97%14.51M114.19%4.56M348.72%4.55M1,342.64%2.84M2,106.90%2.56M
Non-operating interest expense 30.82%31.07M-0.48%8.69M-8.82%7.91M169.41%9.04M214.70%9.4M609.80%23.75M1,360.03%8.73M211.15%8.68M465.15%3.36M354.49%2.99M
Other net income (expense) -42.22%4.81M152.62%3.68M-18.24%9.92M-33.14%7.89M-80.15%694K322.72%8.32M-1,341.92%-6.99M
Gain on sale of security -------------42.22%4.81M152.62%3.68M-18.24%9.92M-33.14%7.89M-80.15%694K322.72%8.32M-1,341.92%-6.99M
Income before tax -154.06%-225.1M-249.53%-70.09M-2.83%-48.79M-25.11%-48.01M-17.23%-58.21M24.08%-88.6M235.49%46.87M-143.46%-47.45M-63.21%-38.37M-26.96%-49.66M
Income tax -87.01%2.36M-85.10%2.36M0-94.70%8K0627.68%18.19M15.81M1.84M-93.96%151K395K
Net income -112.99%-227.46M-333.20%-72.44M1.01%-48.79M-24.64%-48.02M-16.31%-58.21M10.41%-106.79M189.80%31.07M-152.89%-49.28M-48.10%-38.52M-27.97%-50.05M
Net income continuous Operations -112.99%-227.46M-333.20%-72.44M1.01%-48.79M-24.64%-48.02M-16.31%-58.21M10.41%-106.79M189.80%31.07M-152.89%-49.28M-48.10%-38.52M-27.97%-50.05M
Minority interest income
Net income attributable to the parent company -112.99%-227.46M-333.20%-72.44M1.01%-48.79M-24.64%-48.02M-16.31%-58.21M10.41%-106.79M189.80%31.07M-152.89%-49.28M-48.10%-38.52M-27.97%-50.05M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -112.99%-227.46M-333.20%-72.44M1.01%-48.79M-24.64%-48.02M-16.31%-58.21M10.41%-106.79M189.80%31.07M-152.89%-49.28M-48.10%-38.52M-27.97%-50.05M
Basic earnings per share -66.29%-2.96-271.15%-0.8927.16%-0.597.81%-0.59-11.76%-0.9524.26%-1.78185.25%0.52-118.92%-0.81-16.36%-0.64-1.19%-0.85
Diluted earnings per share -66.29%-2.96-271.15%-0.8927.16%-0.597.81%-0.59-11.76%-0.9524.26%-1.78185.25%0.52-118.92%-0.81-16.36%-0.64-1.19%-0.85
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Market Insights

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
Sample Name
Sample Code
 +78.53%
Sample Name
Sample Code
 +24.06%
Sample Name
Sample Code
 +20.03%
4
Kingchem
301509
+20.02%
5
Hunan Er-kang Pharmaceutical
300267
+20.00%
Unlock Now

Discussing

2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current Show More
Learning From Buffett: Investing Wisely Amid Market Volatility Triggered by Trump's Tariffs
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Sample Name
Sample Code
 261.705
Sample Name
Sample Code
 203.077
Sample Name
Sample Code
 136.410
4
Microsoft
MSFT
383.945
5
Amazon
AMZN
184.740
Unlock Now
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Sample Name
Sample Code
 185.860
Sample Name
Sample Code
 261.705
Sample Name
Sample Code
 146.077
4
Oracle
ORCL
136.410
5
Netflix
NFLX
1085.360
Unlock Now
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Sample Name
Sample Code
 1.950
Sample Name
Sample Code
 0.4589
Sample Name
Sample Code
 0.4100
4
Bakkt Holdings
BKKT
9.491
5
Cipher Mining
CIFR
2.985
Unlock Now

Monetary Policy: Navigating the Fed's Rate Cut Cycle

Changing Fed policy is altering the market math for investors.

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.

- No more -